• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳酸脱氢酶和血清肿瘤标志物预测老年肺腺癌患者的转移状态。

Lactate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma.

机构信息

Shanxi Medical University, Taiyuan, Shanxi, China.

Shanxi Cancer Hospital, Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

出版信息

Cancer Biomark. 2019;26(2):139-150. doi: 10.3233/CBM-190201.

DOI:10.3233/CBM-190201
PMID:31356196
Abstract

BACKGROUND

No tumor biomarker (TM) is available for de novo metastatic lung adenocarcinoma.

OBJECTIVE

To examine the serum levels of carcinoembryonic antigen (CEA), cytokeratin-19 fragments (CYFRA21-1), neuron-specific enolase (NSE), carbohydrate antigen (CA) 19-9, CA125, tissue polypeptide antigen (TPA), tissue polypeptide specific antigen (TPS), and lactate dehydrogenase (LDH) to predict de novo metastatic lung adenocarcinoma.

METHODS

This was a retrospective study of geriatric (⩾ 60 years of age) patients with lung cancer diagnosed at Shanxi Cancer Hospital from 02/2012 to 12/2017. CEA, CYFRA21-1, CA199, NSE, CA125, TPA, and TPS were detected by ELISA and LDH was detected by LDH kit. Their predictive value was assessed using receiver operating characteristic (ROC) curves and multivariable logistic regression.

RESULTS

The positive rates of LDH and TMs were higher in the metastatic group (all P< 0.05). The best single TMs were CYFRA21-1 (70.5% sensitivity) and CA199 (92.0% specificity). When using any two, the best were CYFRA21-1+TPA (77.1% sensitivity) and CA199+TPA or NSE (both 84.1% specificity). High LDH and CA125 statuses were each independently associated with brain, bone, liver, and lung metastases (all P< 0.05).

CONCLUSIONS

Abnormal level of LDH and TMs, alone or in combination, had predictive value for metastasis in geriatric patients with lung adenocarcinoma; these indicators were also associated with the metastatic site.

摘要

背景

目前尚无用于新发转移性肺腺癌的肿瘤标志物(TM)。

目的

检测癌胚抗原(CEA)、细胞角蛋白 19 片段(CYFRA21-1)、神经元特异性烯醇化酶(NSE)、糖链抗原(CA)19-9、CA125、组织多肽抗原(TPA)、组织多肽特异性抗原(TPS)和乳酸脱氢酶(LDH)的血清水平,以预测新发转移性肺腺癌。

方法

这是一项回顾性研究,纳入了 2012 年 2 月至 2017 年 12 月在山西省肿瘤医院诊断为肺癌的老年(≥60 岁)患者。采用酶联免疫吸附试验(ELISA)检测 CEA、CYFRA21-1、CA199、NSE、CA125、TPA 和 TPS,采用乳酸脱氢酶试剂盒检测 LDH。采用受试者工作特征(ROC)曲线和多变量逻辑回归评估其预测价值。

结果

转移组的 LDH 和 TMs 阳性率均较高(均 P<0.05)。单一最佳 TMs 为 CYFRA21-1(敏感性 70.5%)和 CA199(特异性 92.0%)。使用两种 TMs 时,最佳组合为 CYFRA21-1+TPA(敏感性 77.1%)和 CA199+TPA 或 NSE(特异性均为 84.1%)。高 LDH 和 CA125 状态与脑、骨、肝和肺转移均独立相关(均 P<0.05)。

结论

LDH 和 TMs 单独或联合异常水平对老年肺腺癌患者的转移具有预测价值;这些指标也与转移部位有关。

相似文献

1
Lactate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma.乳酸脱氢酶和血清肿瘤标志物预测老年肺腺癌患者的转移状态。
Cancer Biomark. 2019;26(2):139-150. doi: 10.3233/CBM-190201.
2
Standardized uptake value of the primary lesion combined with tumor markers for clinically predicting distant metastasis in de novo lung adenocarcinoma.原发灶标准化摄取值联合肿瘤标志物对初诊肺腺癌远处转移的临床预测价值。
Cancer Med. 2024 Apr;13(7):e6961. doi: 10.1002/cam4.6961.
3
Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.胸苷激酶1联合癌胚抗原、细胞角蛋白19片段和神经元特异性烯醇化酶可提高其对肺癌的诊断价值。
Life Sci. 2018 Feb 1;194:1-6. doi: 10.1016/j.lfs.2017.12.020. Epub 2017 Dec 14.
4
The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.循环CYFRA21-1在肺癌患者转移诊断中的重要作用及其与癌胚抗原和神经元特异性烯醇化酶相比的预后价值。
BMC Cancer. 2017 Feb 2;17(1):96. doi: 10.1186/s12885-017-3070-6.
5
The Combination of CA125 and NSE Is Useful for Predicting Liver Metastasis of Lung Cancer.CA125 与 NSE 的联合检测对肺癌肝转移的预测价值
Dis Markers. 2020 Dec 9;2020:8850873. doi: 10.1155/2020/8850873. eCollection 2020.
6
[Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].血清肿瘤标志物联合检测在肺癌诊断中的临床价值
Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Sep;39(5):832-5.
7
Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.血清生物标志物 CEA 和 LDH 与接受铂类化疗的晚期非小细胞肺癌患者的反应之间的关联。
Thorac Cancer. 2020 Jul;11(7):1790-1800. doi: 10.1111/1759-7714.13449. Epub 2020 May 7.
8
Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.结合癌胚抗原、神经元特异性烯醇化酶和细胞角蛋白片段21-1的血清触珠蛋白在肺癌诊断中的临床应用价值
Asian Pac J Cancer Prev. 2014;15(22):9611-4. doi: 10.7314/apjcp.2014.15.22.9611.
9
Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.肺癌诊断与血清肿瘤标志物联合检测的临床观察
Asian Pac J Cancer Prev. 2013;14(7):4369-71. doi: 10.7314/apjcp.2013.14.7.4369.
10
Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion.肿瘤标志物在鉴别肺腺癌相关恶性胸腔积液与结核性胸腔积液中的应用。
Am J Med Sci. 2024 Aug;368(2):136-142. doi: 10.1016/j.amjms.2024.04.001. Epub 2024 Apr 5.

引用本文的文献

1
Multi-omics model is an effective means to diagnose benign and malignant pulmonary nodules.多组学模型是诊断肺良性和恶性结节的有效手段。
Clinics (Sao Paulo). 2025 Feb 21;80:100599. doi: 10.1016/j.clinsp.2025.100599. eCollection 2025.
2
Risk factors for brain metastasis in lung cancer: an umbrella review of systematic reviews and meta-analyses.肺癌脑转移的危险因素:系统评价和荟萃分析的伞状综述
BMJ Open. 2025 Jan 7;15(1):e087181. doi: 10.1136/bmjopen-2024-087181.
3
A Nomogram Based on Clinicopathological Characteristics for Estimating the Risk of Brain Metastasis from Advanced Gastric Cancer: A Multi-Center Retrospective Clinical Study.
基于临床病理特征的晚期胃癌脑转移风险预测列线图:一项多中心回顾性临床研究
Ther Clin Risk Manag. 2024 Jun 24;20:391-404. doi: 10.2147/TCRM.S460647. eCollection 2024.
4
Preoperative diagnosis of solitary pulmonary nodules with a novel hematological index model based on circulating tumor cells.基于循环肿瘤细胞的新型血液学指标模型对孤立性肺结节的术前诊断
Front Oncol. 2023 May 3;13:1150539. doi: 10.3389/fonc.2023.1150539. eCollection 2023.
5
Advances in the Molecular Landscape of Lung Cancer Brain Metastasis.肺癌脑转移分子格局的进展
Cancers (Basel). 2023 Jan 24;15(3):722. doi: 10.3390/cancers15030722.
6
Elevated lactate dehydrogenase predicts poor prognosis of acute ischemic stroke.乳酸脱氢酶升高预示急性缺血性脑卒中不良预后。
PLoS One. 2022 Oct 7;17(10):e0275651. doi: 10.1371/journal.pone.0275651. eCollection 2022.
7
Lymphocyte percentage as a valuable predictor of prognosis in lung cancer.淋巴细胞百分比是肺癌预后的有价值预测指标。
J Cell Mol Med. 2022 Apr;26(7):1918-1931. doi: 10.1111/jcmm.17214. Epub 2022 Feb 5.
8
A nomogram to predict the overall survival of patients with symptomatic extensive-stage small cell lung cancer treated with thoracic radiotherapy.一种用于预测接受胸部放疗的有症状广泛期小细胞肺癌患者总生存期的列线图。
Transl Lung Cancer Res. 2021 May;10(5):2163-2171. doi: 10.21037/tlcr-21-211.
9
Combining Lactate Dehydrogenase and Fibrinogen: Potential Factors to Predict Therapeutic Efficacy and Prognosis of Patients with Small-Cell Lung Cancer.联合乳酸脱氢酶和纤维蛋白原:预测小细胞肺癌患者治疗疗效和预后的潜在因素
Cancer Manag Res. 2021 May 31;13:4299-4307. doi: 10.2147/CMAR.S300153. eCollection 2021.
10
Carbohydrate antigen 19-9 - tumor marker: Past, present, and future.糖类抗原19-9——肿瘤标志物:过去、现在与未来
World J Gastrointest Surg. 2020 Dec 27;12(12):468-490. doi: 10.4240/wjgs.v12.i12.468.